期刊文献+

血清骨保护素水平与冠状动脉病变的关系 被引量:5

Relationship between serum osteoprotegerin and coronary artery lesion
下载PDF
导出
摘要 目的:探讨血清骨保护素、血脂与冠状动脉病变严重程度的关系。方法:对90例行冠状动脉造影的患者用酶联免疫吸附试验检测血清骨保护素,同时检测血脂。用冠状动脉病变血管的数量和狭窄度积分来代表冠状动脉病变严重程度。以冠状动脉造影阴性作对照并进行多因素Logistic回归等分析。结果:冠心病组患者血清中骨保护素水平明显高于对照组(F=9.203,P<0.05)。骨保护素水平随冠状动脉病变支数的增加而升高(F=7.571,P<0.001)。冠状动脉正常或内腔轻度不规则、单支病变、2支病变、3支病变的患者,其血清中骨保护素水平(μg/L)分别为0.104±0.035,0.111±0.037,0.130±0.084,0.169±0.077。多元回归分析显示血清中骨保护素与冠状动脉严重程度有密切关系(OR=2.4;95%的可信区间为1.4~4.2)。三酰甘油、低密度脂蛋白胆固醇(LDL-C)是具有统计学意义的冠状动脉病变危险因素。结论:血清中骨保护素水平与冠状动脉的进展可能有直接关系。OPG,LDL-C、三酰甘油水平越高,冠状动脉病变越严重。 AIM:To explore the relationship of serum osteoprotegerin (OPG) and serum lipid with the severity level and classification of coronary artery lesions. METHODS:Serum OPG was measured by enzyme linked immunosorbent assay(ELISA) in 90 patients who had received coronary angiography (CAG),and lipid level was also measured.The number of diseased vessels and the coronary artery stenosis score were used to show the severity of coronary atherosclerosis lesions.The data were analyzed with logistic regression. RESULTS:Serum OPG levels in patients with coronary heart disease were significantly higher than those in the control group(F=9.203,P< 0.05). As the severity of coronary lesions increased, there was a significant increase in serum OPG levels(F=7.571,P< 0.001).Serum OPG levels were(0.104± 0.035)μ g/L, (0.111± 0.037)μ g/L,(0.130± 0.084)μ g/L,(0.169± 0.077)μ g/L in patients with normal coronary arteries or luminal irregularities,1 vessel disease,2 vessel disease and 3 vessel disease,respectively. Multiple regression analysis showed that serum OPG levels were closely associated with the severity of coronary artery lesions(odds ratio was 2.4; 95% and confidence interval was 1.4- 4.2).Triglyceride (TG) and low density lipoprotein cholesterol(LDL C) were coronary lesion risk factors with statistical significance. CONCLUSION: Serum OPG may be directly related to the initiation and development of coronary artery lesions. The higher the levels of serum OPG, LDL C and TG are, the more serious the degrees of coronary artery lesions will be.
出处 《中国临床康复》 CSCD 2004年第6期1036-1038,共3页 Chinese Journal of Clinical Rehabilitation
  • 相关文献

参考文献4

二级参考文献23

  • 1Castelli WP, Anderson K, Wilson PW, Levy D, Lipids and risk of coronary heart disease: the Framingham Study. Ann Epidemiol 1992; 2 ( 1 - 2) : 23 - 8.
  • 2Wierzbicki AS, Milchailidis DP, Beyond LDL-C-the importance of raising HDL-C.Curr Med Res Opin 2002:18(1):36-44.
  • 3Hokanson JE. Hypertriglyceridemia and risk of coronary heart disease. Curr Cardiol Rep 2002; 4 (6) : 488 - 93.
  • 4Clearfield MB. The national cholesterol education program adult treatment panel ill guidelines. J Am Osteopath Assoc 2003; 103(1 Suppl 1): 1 -5.
  • 5Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults. Executive summary of the third report of the national cholesterol education program(NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel Ⅲ) . JAMA 2001; 285(19):2486 - 97.
  • 6Packard C, Nunn A, Hobbs R. Futme Forum Editorial Board. High density Lipoprotcin: guardian of the vascular system? Int J Clin Pract 2002; 56(10):761 -71.
  • 7Barbagallo CM, Polizzi F, Severino M, et al. Distribution of risk factors, plasma lipicls, lipoproteins and dyslipidemias in a small Mediterranean inland: the Ustica Project. Nutr Metab Cardiovasc Dis, 2002; 12(5):267 -74.
  • 8Nawawi HM, Nor IM, Noor IM, et al. Current status of coronary risk factors amnng rural Malavs in Malaysia. J Cardiovasc Risk 2002;9(1); 17 -23.
  • 9Menotti A, Lanti M. Coronary risk factors predicting early and late coronary deaths. Heart 2003;89(1): 19 -24.
  • 10Zoratti R. A review on ethnic differences in plasma triglycerides and high-density-Lipoprotein cholesterol: is the lipid pattern the key factor for the low coronary heart disease rate in people of African origin? Eur J Epidemiol 1998; 14(1):9 -21.

共引文献63

同被引文献68

  • 1韩宝玲,张扬,张凤萍.2型糖尿病患者骨质疏松的临床探讨[J].中国实用内科杂志,2001,21(4):214-215. 被引量:15
  • 2温绍君,何士大,卢德宏,汪家瑞,张维君,胡旭东,陈宝田,赵迎新,龚伊红,罗立群.心包肽类激素免疫组织化学及免疫电镜的研究[J].首都医学院学报,1993,14(3):192-195. 被引量:2
  • 3林兵,谢海宝,赵晶晶,文晓林,吕远栋,徐伟红,陶萍华.2型糖尿病患者双能X线骨密度测定[J].中国骨质疏松杂志,2005,11(2):218-220. 被引量:16
  • 4李如意,王秀萍,刘新发,容春莉.冠心病患者血清护骨素水平的临床意义[J].临床荟萃,2005,20(14):814-815. 被引量:3
  • 5张维君,温绍君,刘裕,陈宝田,何士大,洪敏,胡旭东.人类心包心钠素基因转录和表达[J].中华心血管病杂志,1996,24(1):49-51. 被引量:5
  • 6Sanonel WS, Lacey DL, Dunstan CR, et al. Osteoprotegerin:a novel secreted protein involved in the regulation of bone density. Cell. 1997 ( 89 ) : 309-319.
  • 7Browner WS, Lui LY, Cummings SR. Association of serum osteoprotegerin levels with diabetes, stroke, bone density, fractures, and mortality in elderly women. J Clin Endocrinol Metab,2001,86(2) :631- 637.
  • 8Jono S, Ikari Y, Shiol A, et al. Serum osteoprotegerin levels are associated with the presence and severity of comnary artery disease. Circulation, 2002,106 ( 10 ) : 1192-1194.
  • 9Jono S, Ikari Y, Shioi A, et al. Serum osteoprotegerin levels are associated with the presence and severity of coronary artery disease. Circulation, 2002 ( 106 ) : 1192-1194.
  • 10Knudsen ST, Foss CH, Poulsen PI, et al. Increased plasma concentrations of osteoprotegerin in type 2 diabetic patients with micrevascular complications. Eur J Endocrino1,2003 ,149 :39-42.

引证文献5

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部